Correlation Between Neumora Therapeutics, and FormFactor

Can any of the company-specific risk be diversified away by investing in both Neumora Therapeutics, and FormFactor at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neumora Therapeutics, and FormFactor into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neumora Therapeutics, Common and FormFactor, you can compare the effects of market volatilities on Neumora Therapeutics, and FormFactor and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neumora Therapeutics, with a short position of FormFactor. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neumora Therapeutics, and FormFactor.

Diversification Opportunities for Neumora Therapeutics, and FormFactor

-0.16

Correlation Coefficient

Neumora Therapeutics,  FormFactor

Good diversification

The 3 months correlation between Neumora and FormFactor is -0.16. Overlapping area represents the amount of risk that can be diversified away by holding Neumora Therapeutics, Common and FormFactor in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on FormFactor and Neumora Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neumora Therapeutics, Common are associated (or correlated) with FormFactor. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of FormFactor has no effect on the direction of Neumora Therapeutics, i.e., Neumora Therapeutics, and FormFactor go up and down completely randomly.

Pair Corralation between Neumora Therapeutics, and FormFactor

Given the investment horizon of 90 days Neumora Therapeutics, Common is expected to under-perform the FormFactor. In addition to that, Neumora Therapeutics, is 3.56 times more volatile than FormFactor. It trades about -0.11 of its total potential returns per unit of risk. FormFactor is currently generating about -0.01 per unit of volatility. If you would invest  4,479  in FormFactor on October 25, 2024 and sell it today you would lose (189.00) from holding FormFactor or give up 4.22% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Neumora Therapeutics, Common  vs.  FormFactor

Neumora Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neumora Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

FormFactor

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days FormFactor has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy basic indicators, FormFactor is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Neumora Therapeutics, and FormFactor

The main advantage of trading using opposite Neumora Therapeutics, and FormFactor positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neumora Therapeutics, position performs unexpectedly, FormFactor can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in FormFactor will offset losses from the drop in FormFactor's long position.

The idea behind Neumora Therapeutics, Common and FormFactor pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.